These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 21599675)

  • 1. In vivo neutralization of anti-A and successful transfusion of A antigen-incompatible red blood cells in an animal model.
    Oliver C; Blake D; Henry S
    Transfusion; 2011 Dec; 51(12):2664-75. PubMed ID: 21599675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Xenotransplantation and ABO incompatible transplantation: the similarities they share.
    Galili U
    Transfus Apher Sci; 2006 Aug; 35(1):45-58. PubMed ID: 16905361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modeling transfusion reactions and predicting in vivo cell survival with kodecytes.
    Oliver C; Blake D; Henry S
    Transfusion; 2011 Aug; 51(8):1723-30. PubMed ID: 21303367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neutralization of blood group A-antigen by a novel anti-A antibody: overcoming ABO-incompatible solid-organ transplantation.
    Hasegawa Y; Kato Y; Kaneko MK; Ogasawara S; Shimazu M; Tanabe M; Kawachi S; Obara H; Shinoda M; Kitagawa Y; Narimatsu H; Kitajima M
    Transplantation; 2008 Feb; 85(3):378-85. PubMed ID: 18322429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Advancement in the preparation of red cell concentrates and platelet concentrates].
    Inaba S
    Masui; 2011 Jan; 60(1):23-30. PubMed ID: 21348247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Flow cytometry evaluation of red blood cells mimicking naturally occurring ABO subgroups after modification with variable amounts of function-spacer-lipid A and B constructs.
    Hult AK; Frame T; Chesla S; Henry S; Olsson ML
    Transfusion; 2012 Feb; 52(2):247-51. PubMed ID: 21812783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Major ABO-incompatible hematopoietic stem cell transplantation: study of post-transplant pure red cell aplasia and endothelial cell chimerism.
    Mueller RJ; Stussi G; Odermatt B; Halter J; Schanz U; Seebach JD
    Xenotransplantation; 2006 Mar; 13(2):126-32. PubMed ID: 16623806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Erythrocyte substitution and isoagglutinin titer following ABO-incompatible bone marrow transplantation].
    Henneberg-Quester KB; Luboldt W; Schaefer UW; Beelen DW; Quabeck K
    Beitr Infusionsther; 1990; 26():200-4. PubMed ID: 1703830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isoagglutinin adsorption in ABO-incompatible transplantation.
    Genberg H; Kumlien G; Wennberg L; Tydén G
    Transfus Apher Sci; 2010 Oct; 43(2):231-5. PubMed ID: 20667787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiac allotransplantation across the ABO-blood group barrier by the neutralization of preformed antibodies: the baboon as a model for the human.
    Ye Y; Niekrasz M; Kehoe M; Rolf LL; Martin M; Baker J; Kosanke S; Romano E; Zuhdi N; Cooper DK
    Lab Anim Sci; 1994 Apr; 44(2):121-4. PubMed ID: 8028272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical outcomes of ABO-incompatible RBC transfusions.
    Janatpour KA; Kalmin ND; Jensen HM; Holland PV
    Am J Clin Pathol; 2008 Feb; 129(2):276-81. PubMed ID: 18208808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ABO-mismatched platelet transfusions: strategies to mitigate patient exposure to naturally occurring hemolytic antibodies.
    Josephson CD; Castillejo MI; Grima K; Hillyer CD
    Transfus Apher Sci; 2010 Feb; 42(1):83-8. PubMed ID: 20034854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resistance of a subset of red blood cells to clearance by antibodies in a mouse model of incompatible transfusion.
    Liepkalns JS; Cadwell CM; Stowell SR; Hod EA; Spitalnik SL; Zimring JC
    Transfusion; 2013 Jun; 53(6):1319-27. PubMed ID: 23033973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo adsorption of isohemagglutinins with fresh frozen plasma in major ABO-incompatible bone marrow transplantation.
    Webb IJ; Soiffer RJ; Andersen JW; Cohen CA; Freeman A; Sugrue M; Ritz J; Anderson KC
    Biol Blood Marrow Transplant; 1997 Nov; 3(5):267-72. PubMed ID: 9450922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Delayed intravascular haemolysis following multiple asymptomatic ABO-incompatible red blood cell transfusions in a patient with hepatic failure.
    Tormey CA; Stack G
    Vox Sang; 2008 Oct; 95(3):232-5. PubMed ID: 19121188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of emergency cardiac surgery in a patient with alloanti-Ge2.
    Selleng S; Selleng K; Zawadzinski C; Wollert HG; Yürek S; Greinacher A
    Transfus Med; 2009 Feb; 19(1):50-2. PubMed ID: 19302455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How we treat: risk mitigation for ABO-incompatible plasma in plateletpheresis products.
    Fontaine MJ; Mills AM; Weiss S; Hong WJ; Viele M; Goodnough LT
    Transfusion; 2012 Oct; 52(10):2081-5. PubMed ID: 22414003
    [No Abstract]   [Full Text] [Related]  

  • 18. Anti-A isoagglutinin as a risk factor for the development of pure red cell aplasia after major ABO-incompatible allogeneic bone marrow transplantation.
    Lee JH; Lee KH; Kim S; Lee JS; Kim SH; Kwon SW; Kim WK
    Bone Marrow Transplant; 2000 Jan; 25(2):179-84. PubMed ID: 10673677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dr(a) (Cromer-related blood group antigen)-incompatible renal transplantation.
    Nakache R; Levene C; Sela R; Kaufman S; Shapira Z
    Vox Sang; 1998; 74(2):106-8. PubMed ID: 9501409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-A antibody transfused with non-group-specific platelets. Serological abnormalities.
    Thomas L; Tuscany FL; Wilner GD
    Arch Pathol Lab Med; 1981 Jan; 105(1):52-3. PubMed ID: 6893913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.